Related Experiment Video
Updated: Jun 8, 2025
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
3.5K
The next frontier in multiple sclerosis therapies: Current advances and evolving targets
K Trideva Sastri1, N Vishal Gupta1, Anbarasu Kannan2
1Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Shivarathreeshwara Nagara, Bannimantap, Mysuru, India.
European Journal of Pharmacology
|November 4, 2024
Summary
Recent research advances reveal key immune components in multiple sclerosis (MS) pathogenesis. This understanding aids in identifying new therapeutic targets and developing innovative treatments for MS management.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- Multiple sclerosis (MS) is a complex autoimmune disease affecting the central nervous system.
- Understanding the immune system's role in MS pathogenesis is crucial for developing effective treatments.
- Current research focuses on dissecting the intricate molecular and cellular mechanisms underlying MS.
Purpose of the Study:
- To review recent advancements in understanding MS pathogenesis.
- To highlight the genetic and environmental factors influencing MS.
- To identify novel therapeutic targets and approaches for MS management.
Main Methods:
- Analysis of molecular interactions in the immunological cascade of MS.
- Application of advanced technologies: proteomics, genomics, and environmental factor assessment.
- Identification and validation of significant biomarkers for disease activity.
Main Results:
- Significant progress in comprehending immune components driving MS.
- Identification of novel therapeutic targets and development of innovative therapies.
- Enhanced understanding of genetic and environmental influences on MS progression.
Conclusions:
- Recent discoveries provide a deeper insight into MS pathogenesis.
- New therapeutic strategies targeting identified pathways show promise for improved patient care.
- Integrating genetic, environmental, and immunological data is key for future MS research and treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:15Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:29Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1